Low‐dose intravenous cyclophosphamide in systemic sclerosis: an open prospective efficacy study in patients with early diffuse disease

References

• Silver R. M., Warrick J. H., Kinsella M. B., Staudt L. S., Baumann M. H., Strange C. Cyclophosphamide and low‐dose prednisone therapy in patients with systemic sclerosis (scleroderma) with interstitial lung disease. J Rheumatol 1993; 20: 838–44
   PubMed Web of Science ®Google Scholar
• Akesson A., Scheja A., Lundin A., Wollheim F. A. Improved pulmonary function in systemic sclerosis after treatment with cyclophosphamide. Arthritis Rheum 1994; 37: 729–35
   PubMed Web of Science ®Google Scholar
• White B., Moore W. C., Wigley F. M., Xiao H. Q., Wise R. A. Cyclophosphamide is associated with pulmonary function and survival benefit in patients with scleroderma and alveolitis. Ann Intern Med 2000; 132: 947–54
   PubMed Web of Science ®Google Scholar
• Pakas I., Ioannidis J. P. A., Malagari K., Skopouli F. N., Moutsopoulos H. M., Vlachoyiannopoulos P. G. Cyclophosphamide with low or high dose prednisolone for systemic sclerosis lung disease. J Rheumatol 2002; 29: 298–304
   PubMed Web of Science ®Google Scholar
• Airo P., Danieli E., Parrinello G., Antonioli C. M., Cavazzana I., Toniati P., et al. Intravenous cyclophosphamide therapy for systemic sclerosis. A single‐center experience and review of the literature with pooled analysis of lung function test results. Clin Exp Rheum 2004; 22: 573–8
   PubMed Web of Science ®Google Scholar
• Apras S., Ertenli I., Ozbalkan Z., Kiraz S., Ozturk MA., Haznedarglu IC., et al. Effects of oral cyclophosphamide and prednisolone therapy on the endothelial functions and clinical findings in patients with early diffuse systemic sclerosis. Arthritis Rheum 2003; 48: 2256–61
   PubMed Web of Science ®Google Scholar
• Martin‐Suarez I., D'Cruz D., Mansoor M., Fernandes A. P., Khamashta M. A., Hughes G. R. V. Immunosuppressive treatment in severe connective tissue diseases: effects of low dose intravenous cyclophosphamide. Ann Rheum Dis 1997; 56: 481–7
   PubMed Web of Science ®Google Scholar
• D'Angelo S., Cuomo G., Paone C., Collutta E., La Montagna G., Valentini G. Low‐dose intravenous cyclophosphamide in systemic sclerosis: a preliminary safety study. Clin Rheumatol 2003; 22: 393–6
   PubMedGoogle Scholar
• LeRoy E. C., Black C., Fleiscmajer R., Jablonska S., Krieg T., Medsger TA J. r., et al. Scleroderma (systemic sclerosis): classification, subsets and pathogenesis. J Rheumatol 1988; 15: 202–5
   PubMed Web of Science ®Google Scholar
• Valentini G., Medsger TA J. r., Silman A. J., Bombardieri S. The assessment of the patient with systemic sclerosis. Clin Exp Rheumatol 2003; 21((Suppl 29))S1–56
   PubMedGoogle Scholar
• Ogilvie C. M., Forster R. E., Blakemore W. S., Morton J. W. A standardized breath holding technique for clinical measurement of the diffusing capacity of the lung for carbon monoxide. J Clin Invest 1957; 36: 1–17
   PubMed Web of Science ®Google Scholar
• American Thoracic Society Standardization of Spirometry, 1994 update. Am J Respir Crit Care Med. 152. 1107–36
   Google Scholar
• Clements P., Lachenbruch P., Siebold J., White B., Weiner S., Martin R., et al. Inter and intraobserver variability of total skin thickness score (modified Rodnan TSS) in systemic sclerosis. J Rheumatol 1995; 22: 1281–5
   PubMed Web of Science ®Google Scholar
• Poole J. L., Steen V. D. The use of the Health Assessment Questionnaire (HAQ) to determine physical disability in systemic sclerosis. Arthritis Care Res 1991; 4: 27–31
   PubMedGoogle Scholar
• Medsger T. A., Silman A. J., Steen V. D., Black C. M., Akesson A., Bacon P., et al. A disease severity scale for systemic sclerosis: development and testing. J Rheumatol 1999; 26: 2159–67
   PubMed Web of Science ®Google Scholar
• Bazzichi L., Rossi A., De Giorgio F., Gesi M., Lenzi P., Pellegrini A. Clinical improvement in systemic sclerosis resulting from urokinase therapy explained by light and electron microscopy skin examination. Scand J Rheumatol 2003; 32: 261–7
   PubMed Web of Science ®Google Scholar
• Sandqvist G., Eklund M., Akesson A., Nordenskiold U. Daily activities and hand function in women with scleroderma. Scand J Rheumatol 2004; 33: 102–7
   PubMed Web of Science ®Google Scholar